| Literature DB >> 29066881 |
Yu Jin1, Chang Chen1, Zhixin Cao2, Baoqing Sun3, Iek Long Lo4, Tzu-Ming Liu1, Jun Zheng1, Shixue Sun1, Yan Shi5, Xiaohua Douglas Zhang1.
Abstract
In this century, the rapid development of large data storage technologies, mobile network technology, and portable medical devices makes it possible to measure, record, store, and track analysis of large amount of data in human physiological signals. Entropy is a key metric for quantifying the irregularity contained in physiological signals. In this review, we focus on how entropy changes in various physiological signals in COPD. Our review concludes that the entropy change relies on the types of physiological signals under investigation. For major physiological signals related to respiratory diseases, such as airflow, heart rate variability, and gait variability, the entropy of a patient with COPD is lower than that of a healthy person. However, in case of hormone secretion and respiratory sound, the entropy of a patient is higher than that of a healthy person. For mechanomyogram signal, the entropy increases with the increased severity of COPD. This result should give valuable guidance for the use of entropy for physiological signals measured by wearable medical device as well as for further research on entropy in COPD.Entities:
Keywords: COPD; entropy; heart rate variability; irregularity; physiological signal; respiratory pattern
Mesh:
Substances:
Year: 2017 PMID: 29066881 PMCID: PMC5644543 DOI: 10.2147/COPD.S140636
Source DB: PubMed Journal: Int J Chron Obstruct Pulmon Dis ISSN: 1176-9106
Figure 1PRISMA flow diagram.
GRADE analysis: applied entropy to physiologic parameters of COPD
| Primary/secondary outcome | N (arms) | Risk of bias | Inconsistency | Indirectness | Imprecision | Publication bias | Large effect | Overall quality of evidence |
|---|---|---|---|---|---|---|---|---|
| HRV | 46 (3) | No | No | No | No | No | No | +/+/+/+/; high |
| Airflow | 104 (1) | No | No | No | No | No | No | +/+/+/+/; high |
| Hormone secretion | 17 (1) | No | No | No | No | Serious | No | +/+/+/−/; moderate |
| Gait variability | 48 (1) | No | No | No | No | No | No | +/+/+/+/; high |
| Airway pressure | 12 (1) | No | No | No | No | Serious | No | +/+/+/−/; moderate |
| Respiratory sound | 37 (3) | No | No | No | No | No | No | +/+/+/+/; high |
| MMG | 16 (2) | No | No | No | No | No | No | +/+/+/+/; high |
Notes: GRADE working group grades of evidence: high quality, further research is very unlike to change our confidence in the estimate of effect. Moderate quality, further research is likely to have an important effect on our confidence in the estimate of effect and may change the estimate. Low quality, further research is very likely to have an important effect on our confidence in the estimate of effect and is likely to change the estimate. Very low quality, the estimate of effect is uncertain.
Abbreviations: GRADE, grading of recommendations assessment, development, and evaluation; HRV, heart rate variability; MMG, mechanomyogram signal.
Entropy studies for comparison between healthy people and patients with COPD
| Physiologic signals | Study (year) | Entropy method | Location | Number of subjects | Age in years as mean ± SD or range | Gender Ratio (M/F) | Pulmonary function | Entropy result | Jadad score |
|---|---|---|---|---|---|---|---|---|---|
| Heart rate variability | Goulart Cda et al | ApEn and SampEn | Brazil | COPD I: 2 | 61.2±6.7 | 8/2 | FEV1/FVC =46.5±11.6 | Decreases during respiratory sinus arrhythmias | 5 |
| Mazzuco et al | ApEn | Brazil | Stage II to IV: 16 | 66.3±8.4 | 16/0 | FEV1/FVC =44.0±10.8 | Decreases during respiratory sinus arrhythmias | 5 | |
| Borghi-Silva et al | SampEn | Brazil | COPD II: 2 | COPD: 67±7 | COPD: 7/3 | FEV1 % predicted | Increases after 6 weeks of physical training program | 5 | |
| Airflow | Dames et al | SampEn | Brazil | COPD I: 11 | COPD: 66.3±10.2 | N/A | FEV1/FVC: | Decreases with increasing airway obstruction during resting breathing | 5 |
| Gait variability | Yentes et al | SampEn | America | COPD: 20 | COPD: 63.6±9.7 | COPD: 16/4 | FEV1/FVC: | The entropy of gait variability in COPD patients is lower than that of healthy controls while walking | 5 |
| Hormone secretion | Iranmanesh et al | ApEn and Cross-ApEn | America | COPD: 9 | Case: 65±4.3 | COPD: 9/0 | FEV1 % predicted: COPD: 43±6.4 | The entropy of hormone secretion in COPD patients is higher than that in healthy persons during maximal exercise | 5 |
| Airway pressure | Letellier et al | Shannon | France | COPD: 4 | N/A | N/A | N/A | Less than 1 means the quality of patient-ventilator interactions during NIV is high | 4 |
| Respiratory sound | Mendes et al | Shannon | Portugal | Online breath sounds datasets of COPD | N/A | N/A | N/A | Higher in presence of cracks | / |
| Mondal et al | SampEn | India | COPD/ILD/asthma: 20 | N/A | N/A | N/A | Higher in abnormal subjects | 5 | |
| Aydore et al | Renyi | America | COPD/asthma: 7 | 50±17 | 4/3 | N/A | Higher in presence of wheezes | 4 | |
| Mechanomyogram signal | Torres et al | Renyi | Spain | COPD III: 6 | 68.2±9.6 | N/A | FEV1/FVC =41.0±8.1 | Increases with increased inspiratory pressure | 4 |
| Sarlabous et al | SampEn | Spain | COPD III: 5 | COPD III: 72.8±9.6 | COPD III 5/0 | FEV1 % predicted: COPD III: 40.0±6.5 | Higher in very severe COPD patients than in severe COPD patients | 5 |
Note:
Smoking subjects that presented a normal respiratory response to the spirometric exam.
Abbreviations: ApEn, approximate entropy; cross-ApEn, cross-approximate entropy; FEV1, forced expiratory volume in 1 second; fSampEn, fixed sample entropy; GOLD, Global Initiative for Chronic Obstructive Lung Disease; ILD, interstitial lung disease; NIV, noninvasive ventilation; OHS, obesity hypoventilation syndrome; SampEn, sample entropy; N/A, not available.
Figure 2Entropy change in COPD.
Notes: The error bar represents standard error. First part uses approximate entropy and sample entropy as mentioned in Goulart Cda et al.1 Second part uses sample entropy as mentioned in Borghi-Silva et al.3 Third part uses sample entropy as mentioned in Dames et al.4 ^Smoking subjects that presented a normal respiratory response to the spirometric exam. Fourth part uses fixed sample entropy as mentioned in Sarlabous et al.11
Abbreviations: HRV, heart rate variability; MMG, mechanomyogram signal; RSA-M, respiratory sinus arrhythmia maneuver.